查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1612943

基孔肯雅热市场：按类型、最终用户划分 - 全球预测 2025-2030

Chikungunya Market by Type (Diagnosis, Treatment), End-Users (Diagnostic Centers, Hospitals & Clinics, Research Institutions) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年基孔肯雅热市值为5.2933亿美元，预计2024年将达5.6511亿美元，复合年增长率为6.89%，预计到2030年将达到8.4397亿美元。

基孔肯雅热是一种由蚊子传播的病毒性疾病，由于零星爆发和相关的令人衰弱的关节疼痛，越来越被认为是一个公共卫生问题。此市场研究的范围包括基孔肯雅热流行病学、预防、治疗和管理策略，以及疫苗和治疗开发的监测。需要进行全面的市场分析，因为基孔肯雅热造成的全球健康负担，推动了对有效疫苗和抗病毒药物的需求。应用和最终用途包括製药、医疗机构、公共卫生政策框架和病媒控制机制。关键的成长要素包括意识的提高、政府对研究的资助以及蚊子控制技术的进步。由于热带和亚热带地区库蚊活动范围的扩大以及疾病发病率的增加，潜在的市场机会正在扩大。然而，市场开拓受到低收入地区基础设施不足、疫苗开发复杂以及来自登革热和疟疾等其他蚊媒疾病的竞争的限制。

主要市场统计
基准年[2023] 52933万美元
预计年份 [2024] 56511万美元
预测年份 [2030] 8.4397 亿美元
复合年增长率（%） 6.89%

此外，疫苗分发和公众接受新产品方面的文化和后勤挑战可能会阻碍市场渗透。创新和研究的机会在于开发具有成本效益且可扩展的病媒控制解决方案、推进疫苗试验以及改善缓解症状的治疗性介入。专注于基因编辑以减少蚊子繁殖或传播的研究可能具有变革性。此外，开发用于早期检测和远端医疗咨询的行动医疗技术可以提高疾病管理的效率。基孔肯雅热市场表现出週期性需求模式，通常在流行病期间激增，并受到旅行和气候变迁等因素的影响，这表明需要采取适应性市场策略。公司可以利用与当地卫生当局的合作伙伴关係以及对意识计划的投资来提高产品的使用率。研发方面的策略伙伴关係可以进一步加速新颖解决方案的部署，满足趋势市场和新兴市场的需求。

市场动态：揭示快速发展的基孔肯亚市场的关键市场洞察

供需的动态交互作用正在改变基孔肯雅热市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 全球基孔肯雅病毒盛行率上升
    • 支持监管机构的国际卫生法规和政策
    • 增加政府和非政府措施以提高意识
  • 市场限制因素
    • 与研发相关的高成本
  • 市场机会
    • 基孔肯雅热诊断技术与治疗方案的进展
    • 整合远端医疗服务来管理基孔肯雅热
  • 市场挑战
    • 基孔肯雅热疫苗开发与生产的复杂性

波特的五力：驾驭基孔肯雅热市场的策略工具

波特的五力架构是了解基孔肯雅热市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解基孔肯雅热市场的外部影响

外部宏观环境因素在塑造基孔肯雅热市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解基孔肯雅热市场的竞争状况

对基孔肯雅热市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 基孔肯雅热市场定位矩阵供应商绩效评估

FPNV 定位矩阵是评估基孔肯雅热市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议绘製基孔肯雅热市场的成功之路

基孔肯雅热市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 基孔肯雅病毒全球盛行率增加
      • 支持监管机构的国际卫生法规和政策
      • 加强政府和非政府努力提高意识
    • 抑制因素
      • 研发成本高
    • 机会
      • 基孔肯雅热诊断技术与治疗方案的进展
      • 透过远端医疗服务和远端医疗整合管理基孔肯雅热
    • 任务
      • 基孔肯雅热疫苗开发与生产的复杂性
  • 市场区隔分析
    • 类型：加强基孔肯雅热下一代治疗方法的研发
    • 最终用户：酷拉布
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 基孔肯雅市场：依类型

  • 诊断
    • 血清学检测
    • 病毒检测测试
  • 治疗

第 7 章 基孔肯雅市场：依最终用户分类

  • 诊断中心
  • 医院/诊所
  • 调查机构

第八章美洲基孔肯雅热市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章 亚太地区基孔肯雅热市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第10章 欧洲、中东和非洲的基孔肯雅热市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • FDA核准Ixchiq：针对高危险成人的基孔肯雅热新疫苗
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company（BD）
  • BioMedomics Inc.
  • Cellex, Inc.
  • Chembio Diagnostic Systems, Inc. by Biosynex
  • Creative Diagnostics
  • ELITechGroup by Bruker Corporation
  • Eurofins Scientific Ltd.
  • F. Hoffmann La-Roche Ltd
  • Grifols Diagnostic Solutions Inc.
  • Immucor, Inc.
  • Quest Diagnostics
  • Randox Laboratories Ltd.
  • Serological Research Institutes
  • Thermo Fisher Scientific, Inc.
Product Code: MRR-CD5A9334D93F

The Chikungunya Market was valued at USD 529.33 million in 2023, expected to reach USD 565.11 million in 2024, and is projected to grow at a CAGR of 6.89%, to USD 843.97 million by 2030.

Chikungunya, a mosquito-borne viral disease, has been increasingly recognized as a public health concern due to sporadic outbreaks and its associated debilitating joint pain. The scope of this market research encompasses the epidemiology, prevention, treatment, and management strategies for chikungunya, alongside monitoring vaccine and therapeutic developments. The necessity for comprehensive market analysis lies in the global health burden posed by chikungunya, driving demand for effective vaccines and anti-viral drugs. Application and end-use span across pharmaceuticals, healthcare institutions, public health policy frameworks, and vector control mechanisms. Key growth influencers include rising awareness, government funding for research, and technological advancements in mosquito control. The potential market opportunity is magnified by the expanding geographic range of Aedes mosquitoes and increasing incidences of disease outbreaks in tropical and subtropical regions. However, market growth faces limitations such as insufficient infrastructure in low-income regions, the complexities of vaccine development, and competition with other mosquito-borne disease priorities like dengue and malaria.

KEY MARKET STATISTICS
Base Year [2023] USD 529.33 million
Estimated Year [2024] USD 565.11 million
Forecast Year [2030] USD 843.97 million
CAGR (%) 6.89%

Moreover, cultural and logistical challenges in vaccine distribution and public acceptance of new products may hinder market penetration. Opportunities for innovation and research lie in developing cost-effective and scalable vector control solutions, advancing vaccine trials, and improving therapeutic interventions to alleviate symptoms. Research focusing on genetic editing to reduce mosquito fertility or transmissibility could be transformative. Furthermore, creating mobile health technologies for early detection and telemedicine consultations can augment disease management efficiency. The chikungunya market exhibits cyclic demand patterns, often spiking during outbreaks, and is influenced by factors like travel and climate change, suggesting a need for adaptive market strategies. Businesses can capitalize on collaborations with local health authorities and investing in awareness programs to enhance product uptake. Strategic partnerships in research and development can further accelerate novel solution rollouts, catering to both endemic and emergent markets.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Chikungunya Market

The Chikungunya Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increased prevalence of chikungunya virus globally
    • Supportive international health regulations and policies by regulatory bodies
    • Increasing government and non-government initiatives to raise awareness
  • Market Restraints
    • High costs associated with research and development
  • Market Opportunities
    • Advancements in diagnostic techniques and treatment options for Chikungunya
    • Integration of telemedicine services for remote care to manage Chikungunya
  • Market Challenges
    • Complexities in vaccine development and manufacturing for Chikungunya

Porter's Five Forces: A Strategic Tool for Navigating the Chikungunya Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Chikungunya Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Chikungunya Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Chikungunya Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Chikungunya Market

A detailed market share analysis in the Chikungunya Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Chikungunya Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Chikungunya Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Chikungunya Market

A strategic analysis of the Chikungunya Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Chikungunya Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Beckman Coulter, Inc., Becton, Dickinson and Company (BD), BioMedomics Inc., Cellex, Inc., Chembio Diagnostic Systems, Inc. by Biosynex, Creative Diagnostics, ELITechGroup by Bruker Corporation, Eurofins Scientific Ltd., F. Hoffmann La-Roche Ltd, Grifols Diagnostic Solutions Inc., Immucor, Inc., Quest Diagnostics, Randox Laboratories Ltd., Serological Research Institutes, and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Chikungunya Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Diagnosis and Treatment. The Diagnosis is further studied across Serological Tests and Viral Detection Tests.
  • Based on End-Users, market is studied across Diagnostic Centers, Hospitals & Clinics, and Research Institutions.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increased prevalence of chikungunya virus globally
      • 5.1.1.2. Supportive international health regulations and policies by regulatory bodies
      • 5.1.1.3. Increasing government and non-government initiatives to raise awareness
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with research and development
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in diagnostic techniques and treatment options for Chikungunya
      • 5.1.3.2. Integration of telemedicine services for remote care to manage Chikungunya
    • 5.1.4. Challenges
      • 5.1.4.1. Complexities in vaccine development and manufacturing for Chikungunya
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Rising R&D toward development of next generation treatment for chikungunya
    • 5.2.2. End-Users: Coolab
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Chikungunya Market, by Type

  • 6.1. Introduction
  • 6.2. Diagnosis
    • 6.2.1. Serological Tests
    • 6.2.2. Viral Detection Tests
  • 6.3. Treatment

7. Chikungunya Market, by End-Users

  • 7.1. Introduction
  • 7.2. Diagnostic Centers
  • 7.3. Hospitals & Clinics
  • 7.4. Research Institutions

8. Americas Chikungunya Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Chikungunya Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Chikungunya Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. FDA Approval of Ixchiq: A New Vaccine Against Chikungunya for High-Risk Adults
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Beckman Coulter, Inc.
  • 3. Becton, Dickinson and Company (BD)
  • 4. BioMedomics Inc.
  • 5. Cellex, Inc.
  • 6. Chembio Diagnostic Systems, Inc. by Biosynex
  • 7. Creative Diagnostics
  • 8. ELITechGroup by Bruker Corporation
  • 9. Eurofins Scientific Ltd.
  • 10. F. Hoffmann La-Roche Ltd
  • 11. Grifols Diagnostic Solutions Inc.
  • 12. Immucor, Inc.
  • 13. Quest Diagnostics
  • 14. Randox Laboratories Ltd.
  • 15. Serological Research Institutes
  • 16. Thermo Fisher Scientific, Inc.

LIST OF FIGURES

  • FIGURE 1. CHIKUNGUNYA MARKET RESEARCH PROCESS
  • FIGURE 2. CHIKUNGUNYA MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CHIKUNGUNYA MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CHIKUNGUNYA MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CHIKUNGUNYA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CHIKUNGUNYA MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CHIKUNGUNYA MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS CHIKUNGUNYA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS CHIKUNGUNYA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES CHIKUNGUNYA MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES CHIKUNGUNYA MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC CHIKUNGUNYA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC CHIKUNGUNYA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA CHIKUNGUNYA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CHIKUNGUNYA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. CHIKUNGUNYA MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. CHIKUNGUNYA MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CHIKUNGUNYA MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CHIKUNGUNYA MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CHIKUNGUNYA MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CHIKUNGUNYA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CHIKUNGUNYA MARKET DYNAMICS
  • TABLE 7. GLOBAL CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CHIKUNGUNYA MARKET SIZE, BY SEROLOGICAL TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CHIKUNGUNYA MARKET SIZE, BY VIRAL DETECTION TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CHIKUNGUNYA MARKET SIZE, BY TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CHIKUNGUNYA MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CHIKUNGUNYA MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CHIKUNGUNYA MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS CHIKUNGUNYA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES CHIKUNGUNYA MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC CHIKUNGUNYA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA CHIKUNGUNYA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 144. CHIKUNGUNYA MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 145. CHIKUNGUNYA MARKET, FPNV POSITIONING MATRIX, 2023